title: What is the optimal treatment of stage IIIA-N2 non-small-cell lung cancer after EORTC 08941?
abstract: The results of a randomized trial investigating the role of local therapies after induction chemotherapy in patients with stage IIIA-N2 non-small-cell lung cancer lend themselves to a review of the available evidence and speculation about the routine and future treatment in these patients. An algorithm for future treatment is proposed.
authors.affiliation: Department of Respiratory Medicine, De Pintelaan 185, 9000 Gent, Belgium. jan.vanmeerbeeck@ugent.be
authors.forename: Jan P
authors.initials: JP
authors.lastname: Van Meerbeeck
authors.forename: Rebecca
authors.initials: R
authors.lastname: De Pauw
authors.forename: Kurt
authors.initials: K
authors.lastname: Tournoy
mesh_terms: D000368:Aged; D000465:Algorithms; D002289:Carcinoma, Non-Small-Cell Lung / Q000401:mortality / Q000473:pathology* / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D018572:Disease-Free Survival; D005060:Europe; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008175:Lung Neoplasms / Q000401:mortality / Q000473:pathology* / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness / Q000473:pathology; D009367:Neoplasm Staging; D011013:Pneumonectomy / Q000379:methods; D018714:Radiotherapy, Adjuvant; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D016019:Survival Analysis; D016896:Treatment Outcome